FDA Approves H.P. Acthar Gel for the Treatment of Infantile Spasms
Links shared publicly online about this topic.
- 791total visits
FDA Approves H.P. Acthar Gel for the Treatment of Infantile Spasms
View full resource at drugs.com
Tags: Children's Health, FDA
Most Recently Shared on October 19, 2010 at 12:33 am By:
FDA Approves H.P. Acthar Gel for the Treatment of Infantile Spasms - http://bit.ly/cZqKuz
Questcor announces launch of H.P. Acthar Gel for infantile spasms
news-medical.net — “Questcor Pharmaceuticals, Inc. today announced that the commercial launch is now underway for H.P. Acthar® Gel (repository corticotropin injection) as monotherapy for the treatment of Infantile Spasms (IS) in infants and children under the age of two years. This new Acthar indication was approved by the U.S. Food and Drug Administration (FDA) on October 15, 2010.” View full resource at news-medical.net
Most Recently Shared on November 3, 2010 at 4:24 pm By:
Epilepsy News: Questcor announces launch of H.P. Acthar Gel for infantile spasms: Questcor Pharmaceuticals, Inc. t... http://bit.ly/aHKU91
FDA Approves H.P. Acthar Gel For The Treatment Of Infantile Spasms - QualityPoint Technologies
qualitypointtech.net — “Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood...” View full resource at qualitypointtech.net
Most Recently Shared on October 16, 2010 at 10:33 pm By:
FDA Approves H.P. Acthar® Gel For The Treatment Of Infantile Spasms: Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR... http://bit.ly/9nP5VZ
FDA Approves H.P. Acthar® Gel For The Treatment Of Infantile Spasms
medicalnewstoday.com — “Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repo” View full resource at medicalnewstoday.com
Most Recently Shared on October 16, 2010 at 1:05 pm By:
MNT Pediatrics News Health News and Pediatrics
FDA Approves H.P. Acthar® Gel For The Treatment Of Infantile Spasms http://mnt.to/3Lkr #pediatrics
Questcor Pharmaceuticals says HP Acthar gel gets FDA approval for infantile spasms indication | Markets | Market News | Canadian Business Online
canadianbusiness.com — “Questcor Pharmaceuticals Inc. said Friday the Food and Drug Administration approved H.P. Acthar Gel” View full resource at canadianbusiness.com
Most Recently Shared on October 15, 2010 at 6:39 pm By:
RT @KimPainter: FDA has just approved long-used-off-label med for a rare form of #epilepsy (ACTH for infantile spasms) http://bit.ly/8Ysmz0
H.P. Acthar Gel approved for infantile spasms - MPR
empr.com — “Questcor announced that the FDA has approved H.P. Acthar Gel (repository corticotropin injection) for the treatment of infantile spasms.” View full resource at empr.com
Most Recently Shared on October 15, 2010 at 5:09 pm By:
MPR News: H.P. Acthar Gel approved for infantile spasms: Questcor announced that the FDA has approved H.P. Acthar ... http://bit.ly/bFcwkN
H.P. Acthar Gel approved for infantile spasms - ONA
oncologynurseadvisor.com — “Questcor announced that the FDA has approved H.P. Acthar Gel (repository corticotropin injection) for the treatment of infantile spasms.” View full resource at oncologynurseadvisor.com
Most Recently Shared on October 15, 2010 at 5:03 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
H.P. Acthar Gel approved for infantile spasms http://goo.gl/fb/f44rD
Questcor Pharmaceuticals provides update on sNDA for H.P. Acthar Gel
news-medical.net — “Questcor Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has informed Questcor that the FDA will require additional time beyond the current action date of September 11, 2010 to complete its review of Questcor's supplemental new drug application for H.P. Acthar Gel (repository corticotropin injection) in the treatment of infantile spasms.” View full resource at news-medical.net
Most Recently Shared on September 9, 2010 at 11:56 am By:
Questcor Pharmaceuticals provides update on sNDA for H.P. Acthar Gel: Questcor Pharmaceuticals, Inc. today announc... http://bit.ly/c1LGHD
FDA advisers support Acthar as treatment for infantile spasms - Related Stories - AAP SmartBrief
smartbrief.com — “An FDA panel endorsed the approval of Questcor Pharmaceuticals' injectable gel Acthar for infantile spasms. The drug is already approved for other indications, including multiple sclerosis. <a href='/servlet/aaRedirect?url2=http%3a%2f%2fwww%2ereuters%2ecom%2farticle%2fidUSN0626892720100506&id2=aa br” View full resource at smartbrief.com
Most Recently Shared on May 8, 2010 at 4:44 am By:
Clara Song Doctor, Pediatrician, and Physician
FDA advisers support Acthar as treatment for infantile spasms http://sbne.ws/r/4EWy
Advertisement
